.jpg "John B. Haanen, MD, PhD photo")
Medical Oncologist
Netherlands Cancer Institute, Netherlands
John Haanen is consultant medical oncologist, scientific group leader at the Division of Molecular Oncology and Immunology, CSO Immunotherapy and Director of the Center for Cellular Therapy at the Netherlands Cancer Institute (NKI) in Amsterdam, Netherlands. Since 2008 he is endowed professor of Translational Immunotherapy of Cancer at Leiden University Medical Center, Leiden, Netherlands. From 2009 till 2018 he headed the Division of Medical Oncology at NKI. Since May 2023 he has a 20% position at CHUV, Lausanne, Switzerland as Head of Melanoma Clinic.
His current research spreads over development of cellular therapies for solid tumors, neoadjuvant immunotherapies (renal cell cancer, involvement in GI cancers and head and neck cancers), and biomarker research. His clinical specialty is in melanoma and other skin cancers, kidney cancer and management of immune-related adverse events. He co-authored over 500 peer-reviewed articles, is currently Editor-in-Chief of ESMO IOTECH. John Haanen was scientific co-chair of ESMO IO Symposium/Congress from 2016-2019, and Scientific Chair of the ESMO 2020 Congress. Since 2018 he is member of the Central Committee for Research involving Human Subjects (CCMO).
